All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Semaglutide 0.25mg: Side Effects

A complete guide to semaglutide 0.25mg side effects. Learn which side effects are common, which are rare, and when to contact your physician.

By Dr. Rachel Nguyen, DO|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Rachel Nguyen, DO · Reviewed by Dr. David Kim, MD, FACE

Semaglutide 0.25mg: Side Effects custom 2026 header image for GLP-1 Weight Loss
Custom header image for Semaglutide 0.25mg: Side Effects, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Semaglutide 0.25mg: Side Effects

A complete guide to semaglutide 0.25mg side effects. Learn which side effects are common, which are rare, and when to contact your physician.

Short answer

A complete guide to semaglutide 0.25mg side effects. Learn which side effects are common, which are rare, and when to contact your physician.

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

A complete guide to semaglutide 0.25mg side effects. Learn which side effects are common, which are rare, and when to contact your physician.

Understanding potential side effects is one of the most important steps when starting any new medication. If you're beginning semaglutide at the 0.25mg dose, you deserve clear, evidence-based information about what might happen, what is considered normal, and what should prompt a call to your physician.

We reviewed the clinical trial data and prescribing information to give you a thorough overview. Keep in mind that side effects vary from person to person, and your physician is always the best resource for managing anything you experience.

Why Side Effects Are Generally Milder at 0.25mg

The 0.25mg dose is the lowest prescribed step in the semaglutide titration schedule. Because the dose is lower, the drug's effects on your GI system are less intense compared to higher doses. Clinical trial data consistently shows that the frequency and severity of side effects are dose-dependent, meaning they increase as the dose goes up.

This is precisely why the titration protocol starts here. By introducing semaglutide gradually, your body has a chance to adapt before the dose increases. Most patients who follow a gradual escalation schedule tolerate the medication better than those who start at higher doses.

Common Side Effects at 0.25mg

The following side effects were reported most frequently in the STEP clinical trial program and in the prescribing information for semaglutide. At 0.25mg, these tend to be milder than at maintenance doses. For a complete cost breakdown, see our cheapest GLP-1 without insurance.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Semaglutide 0.25mg: Side Effects

Nausea

Nausea is the most commonly reported side effect across all semaglutide doses. At 0.25mg, it's typically mild and often described as a background queasiness rather than intense nausea. It tends to be most noticeable in the first 24 to 72 hours after injection and usually improves within the first two weeks of treatment.

Strategies that may help: eat smaller meals, avoid lying down immediately after eating, choose bland foods when nausea is present, and stay well hydrated with small sips of water throughout the day.

Diarrhea

Some patients experience loose stools or increased bowel frequency, particularly during the first week or two. This side effect is usually self-limiting at the 0.25mg dose. Staying hydrated and avoiding high-fat foods can help manage it.

Constipation

On the other end of the spectrum, some patients experience constipation. Semaglutide slows gastric emptying, which can affect the entire digestive tract. Increasing fiber intake gradually, drinking adequate water, and maintaining physical activity can support bowel regularity.

Abdominal Pain or Discomfort

General stomach discomfort, cramping, or a feeling of fullness is reported by some patients. At 0.25mg, this is usually mild. Eating slowly, choosing smaller portions, and avoiding carbonated beverages may reduce discomfort.

Decreased Appetite

While reduced appetite is a desired therapeutic effect for weight management, some patients find it unusual or uncomfortable at first. If you find it difficult to eat enough, focus on nutrient-dense foods and prioritize protein to maintain muscle mass.

Headache

Headaches are reported by some patients, particularly during the first few weeks. These may be related to changes in eating patterns, hydration status, or the medication itself. Ensuring adequate hydration and consistent meal timing can help.

Fatigue

A small number of patients report feeling tired during the initial adjustment period. This is more commonly associated with reduced caloric intake than with the medication directly. Eating balanced meals and getting adequate sleep can mitigate fatigue.

Less Common but Important Side Effects

These side effects occur less frequently but are important to be aware of:

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Vomiting

While nausea is common, actual vomiting is less frequent, especially at the 0.25mg dose. If vomiting occurs and doesn't resolve within a day or two, contact your physician. Persistent vomiting can lead to dehydration and may indicate that a dosing adjustment is needed.

Injection Site Reactions

Redness, swelling, or itching at the injection site can occur but is generally mild and resolves on its own. Rotating injection sites (abdomen, thigh, upper arm) with each dose can help minimize this.

Dizziness

Occasional dizziness has been reported, sometimes related to changes in blood sugar levels. Patients with diabetes or those taking blood sugar-lowering medications should be particularly attentive to this symptom and discuss it with their physician.

Gas and Bloating

Changes in gastric motility can lead to increased gas or bloating. These symptoms are usually temporary and tend to improve as your body adjusts to the medication.

Serious Side Effects: When to Seek Medical Attention

Serious adverse events are rare, particularly at the 0.25mg dose. But you should be aware of the following and contact your physician or seek emergency care if they occur:

Pancreatitis

Severe, persistent abdominal pain that may radiate to the back, with or without vomiting, could indicate pancreatitis. While rare, cases have been reported with GLP-1 receptor agonists. If you suspect pancreatitis, stop the medication and contact your physician immediately.

Gallbladder Problems

Rapid weight loss and GLP-1 agonist use have been associated with gallbladder issues, including gallstones and cholecystitis. Symptoms include sudden, intense pain in the upper right abdomen, fever, nausea, and vomiting.

Allergic Reactions

Severe allergic reactions are very rare but can include swelling of the face, lips, tongue, or throat, difficulty breathing, rapid heartbeat, or severe rash. Seek emergency medical attention if any of these occur.

Kidney Injury

Dehydration caused by nausea, vomiting, or diarrhea can potentially affect kidney function. This is another reason why staying hydrated is so important, especially during the early weeks of treatment.

Thyroid Concerns

Semaglutide carries a boxed warning regarding thyroid C-cell tumors observed in rodent studies. While the relevance to humans hasn't been established, the medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

How Titration Helps Manage Side Effects

The entire purpose of the titration schedule is to minimize the side effects we have discussed. In the STEP clinical trials, the escalation protocol followed this pattern:

  • Weeks 1 through 4: 0.25mg weekly
  • Weeks 5 through 8: 0.5mg weekly
  • Weeks 9 through 12: 1.0mg weekly
  • Weeks 13 through 16: 1.7mg weekly
  • Week 17 onward: 2.4mg weekly

By increasing the dose gradually, each step gives your GI system time to adapt before the next increase. Patients who follow this approach generally report fewer and less severe side effects than those who escalate too quickly. Your physician may modify this timeline based on your tolerance.

What Affects Your Side Effect Profile

  • Previous GI sensitivity: If you have a history of acid reflux, IBS, or other digestive conditions, you may be more susceptible to GI side effects.
  • Diet choices: High-fat, greasy, and overly processed foods can amplify nausea and digestive discomfort.
  • Hydration: Dehydration worsens nearly every GI side effect and increases the risk of kidney complications.
  • Other medications: Drug interactions can influence your side effect experience. Share your complete medication list with your provider.
  • Meal size and timing: Large meals are more likely to trigger nausea when gastric emptying is delayed.

Frequently Asked Questions

How long do side effects last at the 0.25mg dose?

Most GI side effects at this dose are temporary, often resolving within the first one to two weeks. If side effects persist beyond two weeks or worsen, contact your physician for evaluation.

Will side effects get worse when my dose increases?

Some patients experience a temporary return or increase in GI symptoms with each dose escalation. But because your body has already begun adapting during the 0.25mg phase, these symptoms are generally manageable. Your physician will pace your increases based on your tolerance.

Can I take anti-nausea medication while on semaglutide?

Discuss any additional medications with your physician before taking them. Some anti-nausea strategies may be appropriate, and your provider can recommend safe options based on your health profile.

Should I stop semaglutide if I have side effects?

Don't stop your medication without consulting your physician. Many side effects are expected and temporary. But if you experience severe symptoms such as persistent vomiting, severe abdominal pain, or signs of an allergic reaction, contact your physician immediately for guidance.

Expert-Guided Side Effect Management

At FormBlends, our physicians don't simply prescribe and walk away. We monitor your tolerance throughout the titration process and adjust your plan if side effects become difficult to manage. Our goal is to help you get the benefits of GLP-1 therapy with the fewest possible disruptions to your daily life.

Have questions about starting semaglutide? Schedule a consultation with a FormBlends physician to discuss your options and get a personalized treatment plan.

Disclaimer: This content is for educational purposes only and doesn't constitute medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider before starting, stopping, or changing any medication. Individual results vary. Semaglutide is a prescription medication and should only be used under the supervision of a licensed healthcare provider.

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Semaglutide 0.25mg: Side Effects, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Emerging pharmacotherapies for obesity: A systematic review

Broad context for new and established obesity-drug categories.

PubMed

ReviewObesity pharmacotherapy evidence2026

Glucagon-like receptor agonists and next-generation incretin-based medications

Current review for incretin-based obesity medications and cardiometabolic effects.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

Used as a class-level evidence anchor when no more specific citation group matches.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Semaglutide 0.25mg: Side Effects research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

A complete guide to semaglutide 0.25mg side effects. Learn which side effects are common, which are rare, and when to contact your physician. Use "Semaglutide 0.25mg: Side Effects" to make the conversation more specific before you choose a provider, product, or next step. The page leans into safety and side-effect planning and the details behind semaglutide, side effects, safety and pharmacy quality. Because this article has 8 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. The safest takeaway is a better checklist for clinician review, not a do-it-yourself medical decision.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Verify the pharmacy pathway, certificate of analysis, sterility testing, and clinician oversight before trusting a source.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Semaglutide 0.25mg

Semaglutide 0.25mg now carries extra 2026 context around semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, 25mg, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation.

Instead of adding filler, this page keeps the named treatment terms, practical verification points, and next-step questions close to semaglutide 0 25mg side effects.

Readers should use the section to check current eligibility, pharmacy or provider policies, and safety questions with a licensed professional before acting.

Semaglutide 0.25mg custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Semaglutide 0.25mg, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Semaglutide 0.25mg, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by Dr. Rachel Nguyen, DO

Obesity Medicine Specialist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.